Nykredit A/S’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Nykredit A/S's AXSM Position: Q3 2026 in Review
Nykredit A/S held its Axsome Therapeutics (AXSM) position steady in Q3 2026 at 1,597 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #880.
Nykredit A/S first reported a position in AXSM in Q2 2026 and has held it in 2 quarters since. The position peaked at $391K in Q2 2026. 466 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Nykredit A/S held 1,597 shares of Axsome Therapeutics worth $294K as of Q3 2026.
- Nykredit A/S left its Axsome Therapeutics share count unchanged in Q3 2026.
- Axsome Therapeutics made up ﹤0.01% of Nykredit A/S's portfolio in Q3 2026, its #880 holding.
- Nykredit A/S first reported a position in Axsome Therapeutics in Q2 2026 and has held it in 2 quarters since.
- Nykredit A/S's Axsome Therapeutics position peaked at $391K in Q2 2026.
- 466 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Nykredit A/S's 13F filing for Q3 2026, filed 6 Nov 2026.